Prostate Cancer Screening with a PSA Test Leads to Overdiagnosis
A study investigating a single invitation to a PSA blood test to screen for prostate cancer found it had a small impact on reducing deaths.
Read MorePosted by Andy Lundin | Apr 8, 2024 | Prostate |
A study investigating a single invitation to a PSA blood test to screen for prostate cancer found it had a small impact on reducing deaths.
Read MorePosted by Andy Lundin | Apr 4, 2024 | Sequencing Systems |
The collaboration seeks to demonstrate the value of WGS as a first-line genetic test for postnatal diagnosis of developmental delay disorders.
Read MorePosted by Andy Lundin | Mar 29, 2024 | Company News |
Labcorp has long been a partner to Prelude and its network, providing clinical laboratory and FDA-approved donor testing within each clinic.
Read MorePosted by Andy Lundin | Mar 28, 2024 | Molecular Diagnostics |
A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children.
Read MorePosted by Andy Lundin | Mar 25, 2024 | Molecular Diagnostics |
Nucleus Genomics launched a DNA analysis product aimed at expanding access to the benefits of personalized medicine.
Read More